100 - Acute Myeloid Lymphoma Flashcards

1
Q

AML (____) is a neoplastic disease characterized by an _____ of the blood, BM and other tissues by ___, ___, ___ cells from the hematopoietic system

A
Acute myeloid leukemia
Infiltration 
Proliferative
Clonal
Unsorted
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

AML is the most common leukemia in ___ with median age at diagnosis of ___ survival of __ years in 27%

A

Adults
67
5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Most cases of AML are ___. Myeloid leukemia with genetic predisposition are linked to several syndromes of BM failure such as: ____,____. and biological disorders such as dyskeratosis congenital

A

Idiopathic
Fanconi anemia
Schwachman diamond

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

AML is also found in higher rates in patient with ___

A

Trisomy 21

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

In order to diagnose AML there need to be > ___ blasts in the BM/blood, unless there following genetic alteration exist: (3)

A
20%
t(15:17)
t(8:21)
inv(16)
t:(16:16)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The mutation ____ is linked with very good prognosis with ___ cure rate

A

t(15:17)

85%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

The mutations ____ and ____are linked with good prognosis with ___ cure rate

A

t(8:21)
inv(16)
55%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

In AML without cytogenic abnormalities there is an ___ with ___ cure rate

A

Intermediate outcome risk

40%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

The worse prognosis is for ___ and ___ genetic changes.

A

t(6:9)

inv(3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Old age is a ___ prognosis in AML, and predicts a more ___ disease and difficulty to withstand therapy

A

Bad

Resistant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

There is a lower response criteria when symptoms such as ___, ___, ___ are present ___ months before the diagnosis

A

Anemia
Leukopenia
Thrombocytopenia
3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Complete remission after blood and BM examination is achieved according to the following: (5)

A
Neutrophils >=1000
Platelets>=100,000 without blasts in circulation
BM blasts <5%
No auer rods  
No extramedullary leukemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

The common clinical symptoms in AML include: (5)

A
  1. Fatigue
  2. Lethargy
  3. Anorexia and weight loss
  4. Fever
  5. Abnormal hemostasis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Less common clinical symptoms in AML include: (5)

A
Bone pain
Lymphadenopathy
Non specific cough
Headache
Sweating
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is myeloid sarcoma (rare)?

A

A tumor mass consisting of myeloid blasts occuring at anatomic sites other than bone marrow (skin, LN, GI, sot tissue, testis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Most AML patients will present with non severe ___. usually normocytic normochromic with a decrease in ___.

A

Anemia

Reticulocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

It is recommended to treat most AML patients with anemia and thrombocytopenia with ____ even if the decrease is not severe

A

Blood products

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

The median of white count in AML patients is ___. Older patients will present with ____ counts

A

15K

Lower

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

In AML patients 25-40% of patients will present with leukocytes count of ____

20
Q

In AML patients 20% of patients will present with leukocytes count of ____

A

> 100,000K

21
Q

____ are not always present, but when they do the diagnosis is certain

22
Q

In AML patients 75% of patients will present with platelets count of ____

23
Q

In AML patients 25% of patients will present with platelets count of ____

24
Q

50% of AML patients present a slight elevation in ___ when diagnosed. In 10% of patients it will sink in the kidneys, rarely leading to ____

A

Uric acid

Renal Failure

25
In AML chemotherapy may lead to substantial ____, therefore all patients will be treated with ___ or ___ when chemo starts.
Hyperuricemia Alopurinol Rasburicase
26
What are the two stages when treating AML?
1. Induction | 2. Post remission (consolidation)
27
One of the most important factors when choosing the suitable treatment in AML is ___. When
Age | 60
28
What is the induction therapy drugs for AML patients <60?
Cytarabine + Anthracycline (daunorubicin, idarubicin, mitoxantrone)
29
Young AML patients who did not get to the point of remission after induction will go through:
A second round of induction
30
Consolidation therapy in young AML patients include:
Intense chemotherapy for 2+4 cycles + BM transplantation (allogenic autologous)
31
Consolidation therapy in old AML patients include:
Reduced chemotherapy | Allogenic BM transplantation if possible
32
Supportive therapy in AML patients include central line and the following: (2)
1. Platelets infusion keeping the levels > 10K | 2. RBC infusion keeping Hgb levels > 7-9
33
APL has long term prognosis of ___
85%
34
10% of patients who receive the normal protocol die because of ___ due to particles released from the ___ in the blasts
DIC | Auer rods
35
APL leukemic cells are: ___
t(15:17)
36
The drug of choice in APL is:___ which does not cause ___
Tretinoin | DIC
37
Post remission treatment = __
consolidation
38
Without consolidation therapy, all AML patients will experience __
relapse
39
The goal of consolidation therapy is to __ all of the residual __ cells
eradicate | lukemia
40
Young patients are recommended to go through intensive chemotherapy consolidation therapy:
``` high dose cytarabine for 2+4 cycles + BM transplantation (HSCT) allogenic / autologous ```
41
Old patients are recommended to go through reduced chemotherapy consolidation therapy. ___ transplantation should be considered in patients < __ without ___ illness and __ match
Allogenic 75 background HLA
42
The leading mortality cause in AML patients is __. All patients will develop __ during the treatment, but only half will have __
infection fever infection
43
Neutropenic patients should be treated with __ and __ when going through __ and __ therapy. Patients with positive __/__ should be treated with prophylaxes __
``` Abx antifungal induction consolidation VZV herpes antiviral ```
44
The recommended monotherapy Abx are: 3
Imipenem-cilastatin meropenem piperacillin cephalosporine
45
If a neutropenic AML patient suffers from fever under treatment for 4-7 days, we should consider __ treatment: 3
antifungal caspofungin voriconazole liposomal amphotericin B
46
A neutropenic AML patient with fever should continue Abx and/or antifungal until the source of __ is found or the patients is no longer __
infection | neutropenic